Biotech stocks in Hong Kong continue to rally amid hopes of AI-driven development. Bernstein senior analyst Rebecca Liang explains why investors are becoming more optimistic about biotech stocks than last year. She spoke on "Bloomberg: The China Show." (Source: Bloomberg)
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.